
A radioactive substance injected into the body to highlight a target organ for imaging.A radioactive tracer is a substance containing a radioactive isotope that is introduced into a biological system, typically the human body, to track physiological processes or highlight specific organs for imaging. In nuclear medicine, tracers like technetium-99m or fluorine-18 are attached to molecules that accumulate in particular tissues, allowing doctors to see metabolic activity, blood flow, or tumor growth. The emitted gamma rays or positrons are detected by cameras to produce functional images.
The concept dates back to the 1920s with George de Hevesy, who used radioactive lead to study plant metabolism and later developed the tracer principle. Technetium-99m was introduced in the 1960s and became the most widely used medical isotope.
The tracer is injected, inhaled, or swallowed, and it travels through the body, concentrating in target organs based on its chemical properties. For gamma emitters, a gamma camera detects the radiation and builds a 2D or 3D map of its distribution. For positron emitters (like fluorine-18), the positron annihilates with an electron, producing two gamma rays that are detected in coincidence by a PET scanner, giving precise localization.
It is used in PET and SPECT imaging to diagnose cancers, heart disease, and neurological disorders, and to monitor treatment response, such as in chemotherapy for glioblastoma.
The most common tracer, technetium-99m, has a half-life of about 6 hours — long enough to perform a scan but short enough to minimize radiation exposure to the patient.










